Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)

By Koinis Filippos   Polyzos Aristidis   Christopoulou Athina   Zafeiriou Zafeiris   Emmanouilidis Christos   Papadimitraki Elisavet   Kalykaki Antonia   Kalbakis Kostas   Samonis George   Georgoulias Vassilis  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 819-825

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of pegylated liposomal doxorubicin (Caelyx&unknown;) as induction chemotherapy for patients with squamous cell cancer of the head and neck

By Harrington K.J.   Lewanski C.   Northcote A.D.   Whittaker J.   Peters A.M.   Vile R.G.   Stewart J.S.W.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2015-2022

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy

By Harrison Lawrence   Bryan Margarette   Pliner Lilian   Saunders Tracie  

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1407-1413

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

By Lind Pehr   Naucler Gisela   Holm Agneta   Gubanski Michael   Svensson Christer  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 230-233

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness Analysis of Pegylated-liposomal Doxorubicin and Liposomal Daunorubicin Treatments in Patients with Kaposi's Sarcoma

By Hjortsberg Catharina   Persson Ulf   Lidbrink Elisabet   Bennett Charles  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1063-1067

Informa Healthcare

Access to resources Recommend Favorite